Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: pappy who wrote (525)	4/19/1998 10:50:00 AM
From: yosid	Read Replies (1) \| Respond to of 1754

Pappy I was always aware that Summit had more patents registered than Visx. Also, having followed the litigation for many years, I could not remember at any time when BEAM lost a patent fight in or out of the USA. With no real grasp on the technical value of the patents however, I still leave it to the technicians to determine which patents are more valuable. Now that the FTC is questioning some of the patent positions of VISX, one must ask what will be the strength of their patent portfolio if the FED rules against them? Can you break up and determine separate values for the rights of Summit and Visx , and charge new machine manufacturers accordingly? What will be the ratios of royalties after the Fed decisions? Anyone here have any comments?